Publications
Detailed Information
Haloperidol regulates the phosphorylation level of the MEK-ERK-p90RSK signal pathway via protein phosphatase 2A in the rat frontal cortex
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Se Hyun | - |
dc.contributor.author | Seo, Myoung Suk | - |
dc.contributor.author | Jeon, Won Je | - |
dc.contributor.author | Yu, Hyun-Sook | - |
dc.contributor.author | Park, Hong Geun | - |
dc.contributor.author | Jung, Gyung-Ah | - |
dc.contributor.author | Lee, Hee Young | - |
dc.contributor.author | Kang, Ung Gu | - |
dc.contributor.author | Kim, Yong Sik | - |
dc.date.accessioned | 2010-03-25T06:09:05Z | - |
dc.date.available | 2010-03-25T06:09:05Z | - |
dc.date.issued | 2008-02-15 | - |
dc.identifier.citation | International Journal of Neuropsychopharmacology 11, 509-517 | en |
dc.identifier.issn | 1461-1457 (Print) | - |
dc.identifier.uri | https://hdl.handle.net/10371/62001 | - |
dc.description.abstract | Haloperidol, a classical antipsychotic drug, affects the extracellular signal-regulated kinase (ERK) pathway in the brain. However, findings are inconsistent and the mechanism by which haloperidol regulates ERK is poorly understood. Therefore, we examined the ERK pathway and the related protein phosphatase 2A (PP2A) in detail after haloperidol administration. Haloperidol (0.5 and 1 mg/kg) induced biphasic changes in the phosphorylation level of mitogen-activated protein kinase kinase (MEK), ERK, and p90 ribosomal S6 kinase (p90RSK) without changing Raf-1 phosphorylation. Fifteen minutes after haloperidol administration, MEK-ERK-p90RSK phosphorylation increased, whilst PP2A activity decreased. At 60 min, the reverse was observed and the binding of PP2A to MEK and ERK increased. Higher dosages of haloperidol (2 and 4 mg/kg), affected neither MEK-ERK-p90RSK phosphorylation nor PP2A activity. Accordingly, PP2A regulates acute dose- and time-dependent changes in MEK-ERK-p90RSK phosphorylation after haloperidol treatment. These findings suggest the involvement of a dephosphorylating mechanism in the acute action of haloperidol. | en |
dc.language.iso | en | en |
dc.publisher | Cambridge University Press | en |
dc.subject | Animals | en |
dc.subject | Antipsychotic Agents/*pharmacology | en |
dc.subject | Blotting, Western | en |
dc.subject | Dose-Response Relationship, Drug | en |
dc.subject | Extracellular Signal-Regulated MAP Kinases/genetics/*physiology | en |
dc.subject | Haloperidol/*pharmacology | en |
dc.subject | Immunoprecipitation | en |
dc.subject | Male | en |
dc.subject | Mitogen-Activated Protein Kinases/genetics/*physiology | en |
dc.subject | Phosphoprotein Phosphatases/metabolism | en |
dc.subject | Phosphorylation/drug effects | en |
dc.subject | Prefrontal Cortex/drug effects/enzymology/*physiology | en |
dc.subject | Protein Phosphatase 2/*physiology | en |
dc.subject | Proto-Oncogene Proteins c-raf/genetics/physiology | en |
dc.subject | Rats | en |
dc.subject | Rats, Sprague-Dawley | en |
dc.subject | Ribosomal Protein S6 Kinases, 90-kDa/genetics/*physiology | en |
dc.subject | Signal Transduction/*drug effects | en |
dc.subject | raf Kinases/physiology | en |
dc.title | Haloperidol regulates the phosphorylation level of the MEK-ERK-p90RSK signal pathway via protein phosphatase 2A in the rat frontal cortex | en |
dc.type | Article | en |
dc.contributor.AlternativeAuthor | 김세현 | - |
dc.contributor.AlternativeAuthor | 서명석 | - |
dc.contributor.AlternativeAuthor | 전원제 | - |
dc.contributor.AlternativeAuthor | 유현숙 | - |
dc.contributor.AlternativeAuthor | 박홍근 | - |
dc.contributor.AlternativeAuthor | 정경아 | - |
dc.contributor.AlternativeAuthor | 이희영 | - |
dc.contributor.AlternativeAuthor | 강영구 | - |
dc.contributor.AlternativeAuthor | 김용식 | - |
dc.identifier.doi | 10.1017/S1461145707008292 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.